flu

Three ways healthcare executives can uncover consumers at risk for fluWith influenza activity increasing sharply, here’s how healthcare executives can determine which health plan members are at risk for the flu.
ACIP issues recommendations on flu vaccine, third dose of MMRThe Advisory Committee on Immunization Practices (ACIP) is reporting that despite the lack of an intranasal option, there has been no substantial decline in flu vaccination among children.
Flu vaccine recommendations for the 2016 - 2017 seasonEgg allergies are no longer a contraindication for influenza vaccination, but intranasal mists won’t be an alternative for the shot during this year’s flu season, either, according to new recommendations released by the American Academy of Pediatrics.
Live attenuated influenza vaccine “shelved” for poor efficacyRecent data has revealed the live attenuated influenza vaccine (LAIV), also known as the “nasal spray” vaccine, to be grossly ineffective, leading to the ACIP’s decision not to recommend its usage. As such, healthcare providers must be judicious in their choice of influenza vaccine with their patients.
5 things to know about the new seasonal flu vaccine
Visterra gets $29 million to develop novel flu drugA novel influenza drug will advance in development, thanks to funding from the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR).
Children with cerebral palsy, epilepsy need flu vaccine but don’t always get itChildren who have neurological disorders such as cerebral palsy or epilepsy are no more likely to be vaccinated against influenza than children without these conditions, despite the increased risk for complications from flu these children experience, according to a study published online April 9 in Vaccine. Moreover, healthcare providers may not be familiar with the increased risk among these patients to effectively recommend influenza vaccine.
Study: Tamiflu shortens length of flu symptomsAntiviral drug oseltamavir (Tamiflu, Roche) shortens the length of flu symptoms by about 1 day, and reduces respiratory infections that sometimes develop by 44%, according to a study published in The Lancet.
Pharmacist counters CDC antivirals for flu alertThe Centers for Disease Control’s new guidance that hospitalized and high-risk patients with unconfirmed but suspected flu should be administered anti-virals without waiting may cause additional medication shortages, according to a pharmacist and professor.
Fighting the flu: Physicians can begin using new molecular flu test in their offices